| Similar Articles |
|---|
 |
Fast Company
April 2004
Keith H. Hammonds |
Moment of Truth? It has been a tortuous year for Harry M. Jansen Kraemer Jr., CEO of Baxter International Inc. Back in November 2002, we lauded Kraemer's forthright leadership as his company confronted the deaths of 53 patients due to contaminated dialysis filters made by a Baxter subsidiary. Now Kraemer is out of a job.   |
HBS Working Knowledge
September 29, 2003
Michael Sisk |
Do the Right Thing How does a commitment to "do the right thing" as it's applied to customers, employees, and other stakeholders affect an organization's daily decision making? |
Chemistry World
December 6, 2012
Andrew Turley |
Baxter to pay $4bn for dialysis firm US drug maker Baxter has struck a deal to buy privately-owned Swedish firm Gambro, which makes dialysis products, for $4 billion |
The Motley Fool
April 10, 2008
Brian Orelli |
The News for Baxter Just Got Worse These heparin-related deaths aren't associated with Baxter's product, but they still might spell trouble for the company. |
The Motley Fool
November 3, 2011
Dan Caplinger |
Has Baxter International Become the Perfect Stock? Baxter needs to keep working on getting its debt levels down and seek out new growth opportunities. With favorable demographic winds at its back, Baxter could be the rare stock to actually reach perfection. |
Pharmaceutical Executive
August 1, 2014
Ben Comer |
Pharm Exec's 2014 Emerging Pharma Leaders This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise. |
Chemistry World
March 28, 2014
Phillip Broadwith |
Baxter aims to divide and conquer US drugmaker Baxter International is spinning off its biopharmaceuticals business to create two independent companies. |
The Motley Fool
April 18, 2008
Brian Orelli |
Recalls Can't Beat Baxter In spite of charges for two recalls, Baxter posts a decent quarter. |
The Motley Fool
April 22, 2005
Brian Gorman |
Baxter Is on the Mend The medical products company continues to right itself for a brighter future. The firm's long-term positioning and diversified business may make it worth a closer look. |
The Motley Fool
July 20, 2007
Brian Orelli |
Baxter's Mixed Message A recall of Baxter BioScience's COLLEAGUE infusion pumps seems to have over-shadowed healthy quarterly earnings reports. |
The Motley Fool
April 17, 2009
Robert Steyer |
The Steady BAX Beat Baxter International's diverse medical offerings continue to produce prosperity. |
The Motley Fool
February 29, 2008
Brian Orelli |
Bigger Recall, No Big Deal Baxter increases its recall of heparin, but investors shouldn't be that worried. |
IndustryWeek
January 1, 2009
David Drickhamer |
Baxter Mexico: IW Best Plants Profile 2008 Lean Medical Marvel: Baxter Mexico transforms its production processes from the bottom up. |
The Motley Fool
October 19, 2007
Brian Orelli |
Baxter Gets Pumped Up Medical-device maker Baxter puts in a nice quarter despite two recent FDA recalls. |
